-
1 Comment
OUE Lippo Healthcare Limited is currently in a long term uptrend where the price is trading 10.1% above its 200 day moving average.
From a valuation standpoint, the stock is 7.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 9.1.
OUE Lippo Healthcare Limited's total revenue rose by 97.0% to $10M since the same quarter in the previous year.
Its net income has dropped by 3724.6% to $-97M since the same quarter in the previous year.
Finally, its free cash flow grew by 119.8% to $584K since the same quarter in the previous year.
Based on the above factors, OUE Lippo Healthcare Limited gets an overall score of 3/5.
| CurrencyCode | SGD |
|---|---|
| ISIN | SG2F86994413 |
| Exchange | SG |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 89M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.16 |
| Dividend Yield | None |
OUE Healthcare Limited, an investment holding company, invests in, owns, and operates healthcare business in Japan, the People's Republic of China, Indonesia, Singapore, and Myanmar. It operates through four segments: Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments. The company is involved in the development of medical facilities, healthcare-related assets, and integrated mixed-use projects; operation of hospitals, clinics, and medical centers; and supplying of medical equipment and pharmaceutical products. It also rents investment properties and assets; and invests in real estate investment trust. The company was formerly known as OUE Lippo Healthcare Limited and changed its name to OUE Healthcare Limited in April 2023. The company was founded in 2010 and is headquartered in Singapore. OUE Healthcare Limited is a subsidiary of OUE Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5WA.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
